Experimental Drug May Offer “Brilliant Hope” for Mesothelioma Treatment
| | | | | | |

Experimental Drug May Offer “Brilliant Hope” for Mesothelioma Treatment

HUHS1015 is a newly-synthesized analogue (chemically similar compound) of the blood pressure drug naftopidil. In the U.S., naftopidil is sold under the brand name Flivas and is also used to treat certain prostate conditions and Raynaud’s disease. In 2014, another Japanese research team published their findings on the anticancer properties of naftopidil, which appears to increase the expression of certain microRNAs associated with programmed cell death (apoptosis). In their new report on HUHS1015, scientists with the Hyogo College of Medicine and the Hyogo University of Health Sciences say the drug not only induced apoptosis in mesothelioma cells as well as naftopidil, but it also triggered necrosis, the premature death of cancer cells. According to author Tomoyuki Nishizaki and colleagues, HUHS1015…

Induction Therapies Improve Mesothelioma Surgery Outcomes
| | | | | | |

Induction Therapies Improve Mesothelioma Surgery Outcomes

An induction therapy is the first in a series of therapeutic measures, which, in the case of mesothelioma, may include chemotherapy, radiation, surgery, immunotherapy or other types of experimental treatments.  Because mesothelioma is so treatment-resistant, most patients require a combination of therapies to see results, an approach that clinicians refer to as “multi-modality.” Dr. Laura Donahoe and her colleagues at Toronto Mesothelioma Research Program recently published their summary of novel induction therapies being test for pleural mesothelioma, including a new protocol that they have developed for radiotherapy prior to mesothelioma surgery. The protocol consists of accelerated hemithoracic (one side of the chest) radiation followed by lung-removing extrapleural pneumonectomy (EPP) surgery. “The rationale behind this protocol is to maximize both the…

PET/CT and Mesothelioma Staging: Better Imaging Techniques are Needed
| | | | |

PET/CT and Mesothelioma Staging: Better Imaging Techniques are Needed

Scientists with the Institute of Diagnostic and interventional Radiology at the University Hospital of Zurich have just released a new study detailing the benefits and limitations of PET/CT. Positron Emission Tomography (PET) is a nuclear medicine imaging technique that produces three-dimensional pictures of functional processes in the body. When combined with computed tomography (CT), which uses x-rays and a computer to produce cross-sectional images, PET can give clinicians a more complete picture of cancer growth and stage. To determine the value of PET/CT in the staging of mesothelioma, the Swiss team analyzed the cases of 62 pleural mesothelioma patients who were undergoing chemotherapy prior to a planned surgery. Since the goal of this induction chemotherapy is to shrink tumors to…

Catheter Path Tumors in Mesothelioma Patients May Be Benign
| | | | | | |

Catheter Path Tumors in Mesothelioma Patients May Be Benign

People suspected of having pleural mesothelioma often have some type of intervention that involves inserting a needle into the pleura. This can happen in order to obtain a tissue sample for diagnosis or to place a catheter to drain off fluid that can accumulate around the lungs. Unfortunately, mesothelioma patients who have these types of interventions are also prone to developing tiny tumors along the path where the needle was inserted. These tumors are usually assumed to be metastatic mesothelioma that was “seeded” by the needle, and are typically treated with targeted radiation. But doctors at the University of Western Australia say clinicians should not be too quick to treat such tumors without confirming the diagnosis with a biopsy. Dr….

Mesothelioma Management: Different Biomarkers Serve Different Functions
| | | | |

Mesothelioma Management: Different Biomarkers Serve Different Functions

Australian researchers have attempted to settle the debate about the value of the newly proposed mesothelioma biomarker fibulin-3 compared with the gold standard biomarker mesothelin.  According to their new report in the journal Thorax, mesothelin is still the best marker for diagnosing mesothelioma but fibulin-3 is better at predicting mesothelioma outcomes. The multi-center study included 153 patients – 82 with pleural mesothelioma, 36 with other types of malignancies causing pleural effusions (excess lung fluid), and 35 with benign effusions. For comparison, the team also measured biomarker levels in the blood plasma of 49 people with non-mesothelioma asbestos-related diseases. Researchers measured mesothelin and fibulin-3 levels in both pleural effusions and blood plasma and determined that mesothelin provides the best diagnostic accuracy,…

Do Mesothelioma Doctors Rely Too Much on CT?
| | |

Do Mesothelioma Doctors Rely Too Much on CT?

A team of researchers in the UK say doctors may be relying too heavily on the results of CT scans to determine which patients should have invasive biopsies for suspected pleural mesothelioma. Examining tumor cells under a microscope is currently the only way to definitively diagnose malignant pleural mesothelioma. However, because getting a cell sample means that a patient has to undergo surgery, doctors typically use non-invasive tests like CT first. CT scans have become an important part of the diagnostic process for malignant pleural mesothelioma. To see how valuable these tests really are for respiratory patients, experts from the Oxford Centre for Respiratory Medicine and the Lancashire Chest Centre in Preston, UK analyzed the CT scans and final diagnoses…

Spinal Procedure for Mesothelioma Pain Relief
| |

Spinal Procedure for Mesothelioma Pain Relief

Pleural mesothelioma patients with severe pain may benefit from a surgical procedure to disable certain pain-conductors in the spinal cord. The procedure, called cordotomy, is the subject of a newly-published report in BMJ Supportive and Palliative Care. Cordotomy is typically performed on patients in severe pain due to cancer or other incurable diseases. It is usually done with a needle under fluoroscopic guidance. Most mesothelioma patients who undergo cordotomies have only local anesthesia. Although the procedure is sometimes offered for patients with advanced mesothelioma, evidence of its effectiveness is still limited. To get a better sense of the value of cordotomy in mesothelioma, British Researchers from the North Wales Centre for Primary Care Research at Bangor University conducted a systematic…

Mesothelioma Symptoms May Benefit from Tuberculosis Drugs
|

Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

Asbestos Mesothelioma Risk Increased By Other Fibers
|

Asbestos Mesothelioma Risk Increased By Other Fibers

Asbestos is a fibrous mineral mined and used for decades in products ranging from insulation to cement, floor and ceiling tiles, adhesives, and friction products. It has been more than forty years since scientists confirmed the link between asbestos and malignant pleural mesothelioma, an aggressive cancer of the lining around the lungs and its use is now heavily regulated in the U.S. In recent years, another mineral called erionite, has also been implicated in mesothelioma cases. Now, a study conducted in France suggests that two other types of mineral particles used in industry may increase the risk of mesothelioma, particularly in people who are also exposed to asbestos. Researchers in Bordeaux, France compared the cases of 1,199 male industrial workers with…

Localized Mesothelioma May Provide Longer Survival
|

Localized Mesothelioma May Provide Longer Survival

Patients with a rare, localized form of pleural mesothelioma may have a better survival outlook than patients with the more common, diffuse variety. That conclusion comes from a team of thoracic surgeons at Cambridge University. Their goal was to determine what, if any, difference in survival could be expected between people with localized malignant mesothelioma (LMM) of the pleura and those with standard pleural mesothelioma. Most pleural mesothelioma patients have a type of cancer that tends to spread quickly in a sheet across the thin membrane that surrounds the lungs. While patients with LMM have identical mesothelioma cells, from a histological perspective, the growth pattern exhibited by these cells is distinctly different. Instead of spreading across the mesothelium, LMM presents as…